GALNT3 gene mutation-associated chronic recurrent multifocal osteomyelitis and familial hyperphosphatemic familial tumoral calcinosis

Scandinavian Journal of Rheumatology

Volumn 44, Issue 2, 2015, Pages 170-172

  El Demellawy, D ^a,b,c   Chang, N ^a,d   De Nanassy, J ^a,b   Nasr, A ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; N ACETYLGALACTOSAMINYLTRANSFERASE; N ACETYLGALACTOSAMINYLTRANSFERASE 3; SEVELAMER; UNCLASSIFIED DRUG; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE;

CASE REPORT; CHILD; CHRONIC DISEASE; DISEASE ASSOCIATION; EXON; GENE MAPPING; GENE MUTATION; HUMAN; HYPERPHOSPHATAEMIC FAMILIAL TUMORAL CALCINOSIS; INTRON; LETTER; MALE; MULTIFOCAL OSTEOMYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SEQUENCE ANALYSIS; TUMOR CALCINOSIS; CALCINOSIS; GENETICS; HYPEROSTOSIS, CORTICAL, CONGENITAL; HYPERPHOSPHATEMIA; MUTATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CALCINOSIS; CHILD; HUMANS; HYPEROSTOSIS, CORTICAL, CONGENITAL; HYPERPHOSPHATEMIA; MALE; MUTATION; N-ACETYLGALACTOSAMINYLTRANSFERASES; OSTEOMYELITIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84924745297     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2014.958100     Document Type: Letter

References (9)

1. Yancovitch A, Hershkovitz D, Indelman M, Galloway P, Whiteford M, Sprecher E, et al. Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis. J Bone Miner Metab 2011;29:621-5.
2. Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007;18:1637-47.
3. Fukumoto S. Physiological regulation and disorders of phosphate metabolism - pivotal role of fibroblast growth factor 23. Intern Med 2008;47:337-43.
4. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006;444:770-4.
5. Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 2004;36:579-81.
6. Kato K, Jeanneau C, Tarp MA, Benet-Pagès A, Lorenz-Depiereux B, Bennett EP, et al. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem 2006;281:18370-7.
7. Ichikawa S, Baujat G, Seyahi A, Garoufali AG, Imel EA, Padgett LR, et al. Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations. Am J Med Genet A 2010;152A:896-903.
8. Maus U, Ihme N, Schroeder S, Andereya S, Ohnsorge JA, Hermanns B, et al. Chronic recurrent multifocal osteomyelitis and tumoral calcinosis - is there an association? [in German] Klin Padiatr 2007;219:277-81.
9. Majeed SA. Chronic recurrent multifocal osteomyelitis associated with tumoral calcinosis. J Bone Joint Surg Br 1994; 76:325-7.